Experimental Models to Study Autism Spectrum Disorders: hiPSCs, Rodents and Zebrafish
Por favor, use este identificador para citas ou ligazóns a este ítem:
http://hdl.handle.net/10347/24038
Ficheiros no ítem
Metadatos do ítem
Título: | Experimental Models to Study Autism Spectrum Disorders: hiPSCs, Rodents and Zebrafish |
Autor/a: | Pensado López, Alba Veiga Rúa, Sara Carracedo Álvarez, Ángel María Allegue Toscano, Catarina Sánchez Piñón, Laura Elena |
Centro/Departamento: | Universidade de Santiago de Compostela. Centro de Investigación en Medicina Molecular e Enfermidades Crónicas Universidade de Santiago de Compostela. Departamento de Ciencias Forenses, Anatomía Patolóxica, Xinecoloxía e Obstetricia, e Pediatría Universidade de Santiago de Compostela. Departamento de Zooloxía, Xenética e Antropoloxía Física |
Palabras chave: | Autism spectrum disorders (ASD) | Animal models | Cellular models | Genome editing | Human induced pluripotent stem cells (hiPSCs) | Neurodevelopmental disorders (NDDs) | Rodents | Zebrafish | |
Data: | 2020 |
Editor: | MDPI |
Cita bibliográfica: | Pensado-López, A.; Veiga-Rúa, S.; Carracedo, Á.; Allegue, C.; Sánchez, L. Experimental Models to Study Autism Spectrum Disorders: hiPSCs, Rodents and Zebrafish. Genes 2020, 11, 1376 |
Resumo: | Autism Spectrum Disorders (ASD) affect around 1.5% of the global population, which manifest alterations in communication and socialization, as well as repetitive behaviors or restricted interests. ASD is a complex disorder with known environmental and genetic contributors; however, ASD etiology is far from being clear. In the past decades, many efforts have been put into developing new models to study ASD, both in vitro and in vivo. These models have a lot of potential to help to validate some of the previously associated risk factors to the development of the disorder, and to test new potential therapies that help to alleviate ASD symptoms. The present review is focused on the recent advances towards the generation of models for the study of ASD, which would be a useful tool to decipher the bases of the disorder, as well as to conduct drug screenings that hopefully lead to the identification of useful compounds to help patients deal with the symptoms of ASD |
Versión do editor: | https://doi.org/10.3390/genes11111376 |
URI: | http://hdl.handle.net/10347/24038 |
DOI: | 10.3390/genes11111376 |
E-ISSN: | 2073-4425 |
Dereitos: | © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/) Atribución 4.0 Internacional |
Coleccións
-
- CFAPXOP-Artigos [199]
- CIMUS-Artigos [249]
- ZAF-Artigos [273]
O ítem ten asociados os seguintes ficheiros de licenza: